Stockreport
Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025
Last illumina, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations: illumina.com/company/investor-information.html
SAN DIEGO, Jan. 13, 2026 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced unaudited preliminary financial results for the fourth quarter and fiscal year 2025 ahead of its presentation at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time). The webcast can be accessed through Illumina's website at investor.illumina.com.Preliminary fourth quarter 2025 results:Revenue of approximately $1.155 billion, up 5% from Q4 2024 (up 4% on a constant currency basis)Ex-China revenue of approximately $1.100 billion, up 7% from Q4 2024 (and on a constant currency basis)GAAP diluted EPS of $2.14 to $2.17 and non-GAAP diluted EPS of $1.27 to $1.30Preliminary fiscal year 2025 results:Revenue of approximately $4.34 billion, flat compared to 2024 (and on a constant currency basis)Ex-China revenue of approximately $4.10 billion, up 2% from 2024 (and on a constant currency basis)GAAP diluted EPS o
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | ILMN | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
ILMN alerts
ILMN alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
ILMN alerts
High impacting Illumina, Inc. news events
Weekly update
A roundup of the hottest topics
ILMN
NEWS
NEWS
- Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery [Yahoo! Finance][Yahoo! Finance]
- Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery[PR Newswire]
- Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026[PR Newswire]
- Illumina Appoints Dr. Eric Green as Chief Medical Officer [Yahoo! Finance][Yahoo! Finance]
- Illumina Appoints Dr. Eric Green as Chief Medical Officer[PR Newswire]
- More
ILMN
SEC Filings
SEC Filings
- 1/13/26 - Form 8-K
- 1/8/26 - Form 8-K
- 1/5/26 - Form 4
- ILMN's page on the SEC website
- More